Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study
Ap. Strafella et al., Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study, CLIN NEU, 111(7), 2000, pp. 1198-1202
Objectives: Transcranial magnetic stimulation was used to assess the effect
s of chronic levodopa and pergolide treatment on motor cortex excitability
in Parkinson disease (PD).
Methods: Motor thresholds, intracortical inhibition and facilitation were s
tudied at baseline and after 6 and 12 months of therapy in 10 PD patients a
nd compared to 7 age-matched controls.
Results: At baseline, there was significantly less intracortical inhibition
with only a slight reduction of intracortical facilitation in PD as compar
ed to controls. Relative to pretreatment condition, levodopa restored intra
cortical inhibition for 12 months while pergolide did not. Intracortical fa
cilitation was always within the normal range. Motor thresholds were unchan
ged in both groups of patients over 12 months. Clinically, levodopa and per
golide improved motor Unified Parkinson's disease rating scale (UPDRS) scor
es at 6 months but only levodopa maintained benefit at 12 months as compare
d to baseline.
Conclusions: Levodopa and pergolide differentially affected cortical inhibi
tory circuits at 12 months. The progressive deterioration of restored intra
cortical inhibition with pergolide may be due to the development of toleran
ce and down-regulation of dopamine receptors. (C) 2000 Elsevier Science Ire
land Ltd. All rights reserved.